Position in CYTK
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$299,528
+$75,962 QoQ
Shares Held
3,516
+3.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#342
of 477 holders
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $32,926,453 across 49 Biotechnology names. CYTK ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,729 | $8,309,796 | |
| 2 | FTRE |
Fortrea Holdings Inc.
|
175,864 | $3,060,033 | |
| 3 | INCY |
Incyte Corp
|
19,250 | $2,182,180 | |
| 4 | ARGX |
Argenx SE
|
2,045 | $1,897,289 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,687 | $1,675,451 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,347 | $1,308,577 | |
| 7 | EXEL |
Exelixis, Inc.
|
20,292 | $1,104,087 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
4,527 | $1,090,871 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $299,528 | 3,516 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $223,566 | 3,392 | Shares | Sole | 2026-04-30 | |
| 2023-12-31 | $262,743 | 3,147 | Shares | Sole | 2024-01-26 | |
| No filing history on record for this holder in this stock. | ||||||